T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roper Technologies
ROP
|
+$840M |
| 2 |
Cigna
CI
|
+$836M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$788M |
| 4 |
Abbott
ABT
|
+$766M |
| 5 |
Becton Dickinson
BDX
|
+$743M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.26B |
| 2 |
Martin Marietta Materials
MLM
|
+$1.05B |
| 3 |
Linde
LIN
|
+$913M |
| 4 |
Intercontinental Exchange
ICE
|
+$865M |
| 5 |
AbbVie
ABBV
|
+$857M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.45% |
| 2 | Healthcare | 20.82% |
| 3 | Consumer Discretionary | 13.33% |
| 4 | Industrials | 10.66% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Structure Therapeutics
GPCR
$3.85B
| – | – |
-715,968
| Closed | -$31.4M |
|
652
Goldman Sachs
GS
$305B
| – | – |
-6,063
| Closed | -$3M |
|
653
Healthcare Realty
HR
$6.62B
| – | – |
-3,451,464
| Closed | -$62.6M |
|
654
Hawkins
HWKN
$2.73B
| – | – |
-50,020
| Closed | -$6.38M |
|
655
Janus International
JBI
$671M
| – | – |
-1,703,905
| Closed | -$17.2M |
|
656
Lifestance Health
LFST
$4.65B
| – | – |
-4,481,379
| Closed | -$31.4M |
|
657
Southwest Airlines
LUV
$22.1B
| – | – |
-1,032,076
| Closed | -$30.6M |
|
658
LegalZoom.com
LZ
$937M
| – | – |
-1,272,405
| Closed | -$8.08M |
|
659
Manhattan Associates
MANH
$11.3B
| – | – |
-71,415
| Closed | -$20.1M |
|
660
Mercury Systems
MRCY
$6.55B
| – | – |
-805,653
| Closed | -$29.8M |
|
661
MSC Industrial Direct
MSM
$6.72B
| – | – |
-794,007
| Closed | -$68.3M |
|
662
Mueller Water Products
MWA
$4.05B
| – | – |
-3,152,099
| Closed | -$68.4M |
|
663
Nkarta
NKTX
$170M
| – | – |
-792,809
| Closed | -$3.58M |
|
664
NerdWallet
NRDS
$625M
| – | – |
-2,725,877
| Closed | -$34.6M |
|
665
nVent Electric
NVT
$27.7B
| – | – |
-310,374
| Closed | -$21.8M |
|
666
Prelude Therapeutics
PRLD
$445M
| – | – |
-281,583
| Closed | -$583K |
|
|
PVBC
667
DELISTED
Provident Bancorp
PVBC
| – | – |
-520,515
| Closed | -$5.62M |
|
668
Rexford Industrial Realty
REXR
$8.15B
| – | – |
-1,297,600
| Closed | -$65.3M |
|
669
Sana Biotechnology
SANA
$1.1B
| – | – |
-374,169
| Closed | -$1.56M |
|
670
Syndax Pharmaceuticals
SNDX
$1.75B
| – | – |
-85,511
| Closed | -$1.65M |
|
|
STR
671
DELISTED
Sitio Royalties
STR
| – | – |
-892,130
| Closed | -$18.6M |
|
672
Bio-Techne
TECH
$11.3B
| – | – |
-428,331
| Closed | -$34.2M |
|
673
Trane Technologies
TT
$106B
| – | – |
-3,276
| Closed | -$1.27M |
|
674
10x Genomics
TXG
$7.66B
| – | – |
-2,161,775
| Closed | -$48.8M |
|
675
Verra Mobility
VRRM
$709M
| – | – |
-2,237,368
| Closed | -$62.2M |
|
Similar funds
T. Rowe Price Investment Management's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Investment Management held 684 positions worth $162B, down 2.2% from $166B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Investment Management's Q4 2024 filing shows 61 new, 276 increased, 294 reduced and 51 closed positions. Its largest new stake was Cigna: 2,623,729 shares worth $725M. The largest sale was Salesforce, an estimated $1.26B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Investment Management's largest Q4 2024 buy was Cigna: 2,623,729 shares worth $725M.
- T. Rowe Price Investment Management added most to Roper Technologies in Q4 2024, an estimated $840M increase.
- T. Rowe Price Investment Management's biggest Q4 2024 reduction was Salesforce, cutting an estimated $1.26B.
- T. Rowe Price Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $278M.
- T. Rowe Price Investment Management's ten largest holdings make up 19% of its $162B portfolio in Q4 2024.
- T. Rowe Price Investment Management opened 61 new positions and closed 51 in Q4 2024.
- T. Rowe Price Investment Management's portfolio value fell 2.2% quarter-over-quarter to $162B.
Based on T. Rowe Price Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.